Intermediate-term outcome of Aurolab aqueous drainage implant
Indian Journal of Ophthalmology, 2019 Purpose: To report the intermediate-term safety and efficacy of Aurolab aqueous drainage implant (AADI) in patients with glaucoma. Methods: Retrospective review of patients who underwent AADI between January 2013 and December 2016.
Reji Philip +4 more
doaj +8 more sources
Use of the Aurolab Aqueous Drainage Implant as a buckling element in pediatric retinal detachment with a preexisting glaucoma drainage device [PDF]
American Journal of Ophthalmology Case Reports, 2023 Purpose: To describe a novel technique for repair of rhegmatogenous retinal detachment in an eye with a previous non-valved glaucoma drainage device, the Aurolab Aqueous Drainage Implant (AADI).
Deeksha Katoch +6 more
doaj +8 more sources
Efficacy and Safety of Aurolab Aqueous Drainage Implant Compared With Baerveldt Glaucoma Implant for Refractory Glaucoma at One Year: A Systematic Review and Meta-Analysis [PDF]
Journal of OphthalmologyConclusion: AADI demonstrates promising results in reducing IOP at 3 months compared to BGI, with comparable surgical outcomes and complication rates over the long term.
Sandesh Raja +5 more
doaj +7 more sources
Aurolab aqueous drainage implant implantation made easy: A video-based step-by-step guide [PDF]
Indian Journal of Ophthalmology, 2023 Background: Glaucoma is one of the major causes of irreversible blindness in the world, with trabeculectomy still being the primary surgical modality for the management of glaucoma.
Devendra Maheshwari +5 more
doaj +6 more sources
Emulsified silicone oil droplets blocking an aurolab aqueous drainage implant [PDF]
BMJ Case Reports, 2020 Glaucoma drainage devices are commonly used nowadays in cases of secondary glaucoma, especially silicone oil (SO) glaucoma. Even after removal of SO from the vitreous and anterior chamber, due to remnant droplets in the drainage tube, intractable ...
Sagnik Sen
exaly +8 more sources
Indian Journal of Ophthalmology, 2021 Glaucoma drainage devices (GDDs) are used for managing refractory glaucoma due to failed trabeculectomy, neovascular glaucoma, traumatic glaucoma, and secondary glaucoma post keratoplasty.
Vinit J Shah +6 more
doaj +6 more sources
Retinal detachment in eyes treated with Aurolab aqueous drainage implant for refractory glaucoma - Incidence and outcomes [PDF]
Indian Journal of Ophthalmology, 2022 Purpose: To analyze the incidence of rhegmatogenous retinal detachment (RRD) in patients who have undergone prior Aurolab aqueous drainage implant (AADI) surgery and report outcomes in terms of anatomic, visual acuity, and intraocular pressure (IOP ...
NareshBabu +3 more
doaj +6 more sources
Indian Journal of Ophthalmology, 2019 Purpose: To evaluate the outcome of a nonvalved Aurolab aqueous drainage implant (AADI) in the management of refractory glaucoma. Methods: Retrospective case series of patients with refractory glaucoma underwent AADI implantation in posterior segment (PS
Devendra Maheshwari +4 more
doaj +7 more sources
Commentary: Retinal detachment in eyes treated with Aurolab aqueous drainage implant for refractory glaucoma - Incidence and outcomes [PDF]
Indian Journal of Ophthalmology, 2022 The principal indication for glaucoma drainage devices (GDDs) is usually glaucoma refractory to filtering surgery.[1] Currently, commonly available GDDs are either valved like the Ahmed glaucoma valve (AGV; New World Medical Inc., Rancho Cucamonga, CA ...
Subhendu Kumar Boral, Arijit Mitra
doaj +7 more sources
Indian Journal of Ophthalmology, 2019 We report a novel simplified method for managing inadvertent tube cut in a patient undergoing the Aurolab aqueous drainage implant (AADI) surgery for refractory neovascular glaucoma.
Sachin Mungale, Paaraj Dave
doaj +6 more sources